Miami Cancer Institute at Baptist Health, Inc. — Miami, Florida

Miami Cancer Institute at Baptist Health, Inc. is a clinical research site located in Miami, Florida, United States 33176.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Miami Cancer Institute at Baptist Health, Inc. has participated in 42 clinical trials with 25 currently active.

Therapeutic areas: Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, Ovarian Cancer.

Sponsors: Regeneron Pharmaceuticals, Pfizer, Seagen Inc..

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Miami Cancer Institute at Baptist Health, Inc.?

Miami Cancer Institute at Baptist Health, Inc. has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Miami Cancer Institute at Baptist Health, Inc. conducted?

Miami Cancer Institute at Baptist Health, Inc. has 42 clinical trials on record, with 25 currently active. Their work covers Cutaneous Squamous Cell Carcinoma, Basal Cell Carcinoma, Ovarian Cancer.

Is Miami Cancer Institute at Baptist Health, Inc. accredited by Crixeo Health?

Miami Cancer Institute at Baptist Health, Inc. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Miami Cancer Institute at Baptist Health, Inc.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.